Product References
In Situ Vaccination Following Intratumoral Injection of IL2 and Poly-l-lysine/Iron Oxide/CpG Nanoparticles to a Radiated Tumor Site.
ACS nano
Zhang Y,Rahman MM,Clark PA,Sriramaneni RN,Havighurst T,Kerr CP,Zhu M,Jones J,Wang X,Kim K,Gong S,Morris ZS
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Tue Jun 13 00:00:00 EDT 2023
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention.
NPJ precision oncology
Lee SB,Pan J,Xiong D,Palen K,Johnson B,Lubet RA,Shoemaker RH,Green JE,Fernando RI,Sei S,You M,Wang Y
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry (Paraffin)
Wed Oct 25 00:00:00 EDT 2023
Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma.
Frontiers in immunology
Digifico E,Erreni M,Mannarino L,Marchini S,Ummarino A,Anfray C,Bertola L,Recordati C,Pistillo D,Roncalli M,Bossi P,Zucali PA,D'Incalci M,Belgiovine C,Allavena P
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Mon Jul 10 00:00:00 EDT 2023
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss.
Cell death & disease
Mejía-Hernández JO,Keam SP,Saleh R,Muntz F,Fox SB,Byrne D,Kogan A,Pang L,Huynh J,Litchfield C,Caramia F,Lozano G,He H,You JM,Sandhu S,Williams SG,Haupt Y,Haupt S
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Thu Sep 08 00:00:00 EDT 2022
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression.
Nature materials
Maller O,Drain AP,Barrett AS,Borgquist S,Ruffell B,Zakharevich I,Pham TT,Gruosso T,Kuasne H,Lakins JN,Acerbi I,Barnes JM,Nemkov T,Chauhan A,Gruenberg J,Nasir A,Bjarnadottir O,Werb Z,Kabos P,Chen YY,Hwang ES,Park M,Coussens LM,Nelson AC,Hansen KC,Weaver VM
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Thu Apr 01 00:00:00 EDT 2021
Exposure to Microbial Metabolite Butyrate Prolongs the Survival Time and Changes the Growth Pattern of Human Papillomavirus 16 E6/E7-Immortalized Keratinocytes in Vivo.
The American journal of pathology
Li M,McGhee EM,Shinno L,Lee K,Lin YL
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Fri Oct 01 00:00:00 EDT 2021
Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis.
Journal of immunology (Baltimore, Md. : 1950)
Bianchi A,Marchetti L,Hall Z,Lemos H,Vacca M,Paish H,Green K,Elliott B,Tiniakos D,Passos JF,Jurk D,Mann DA,Wilson CL
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Mon Feb 15 00:00:00 EST 2021
Multiparametric Analyses of Hepatocellular Carcinoma Somatic Mouse Models and Their Associated Tumor Microenvironment.
Current protocols
Taranto D,Ramirez CFA,Vegna S,de Groot MHP,de Wit N,Van Baalen M,Klarenbeek S,Akkari L
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Tue Jun 01 00:00:00 EDT 2021
STAT3 Signalling via the IL-6ST/gp130 Cytokine Receptor Promotes Epithelial Integrity and Intestinal Barrier Function during DSS-Induced Colitis.
Biomedicines
Pang L,Huynh J,Alorro MG,Li X,Ernst M,Chand AL
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Fri Feb 12 00:00:00 EST 2021
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells.
Communications biology
Vito A,Salem O,El-Sayes N,MacFawn IP,Portillo AL,Milne K,Harrington D,Ashkar AA,Wan Y,Workenhe ST,Nelson BH,Bruno TC,Mossman KL
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Mon Jul 12 00:00:00 EDT 2021
Role of CXCL5 in Regulating Chemotaxis of Innate and Adaptive Leukocytes in Infected Lungs Upon Pulmonary Influenza Infection.
Frontiers in immunology
Guo L,Li N,Yang Z,Li H,Zheng H,Yang J,Chen Y,Zhao X,Mei J,Shi H,Worthen GS,Liu L
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunocytochemistry
Tue Feb 08 00:00:00 EST 2022
A pulsatile release platform based on photo-induced imine-crosslinking hydrogel promotes scarless wound healing.
Nature communications
Zhang J,Zheng Y,Lee J,Hua J,Li S,Panchamukhi A,Yue J,Gou X,Xia Z,Zhu L,Wu X
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry (Paraffin)
Mon Mar 15 00:00:00 EDT 2021
A pulsatile release platform based on photo-induced imine-crosslinking hydrogel promotes scarless wound healing.
Nature communications
Zhang J,Zheng Y,Lee J,Hua J,Li S,Panchamukhi A,Yue J,Gou X,Xia Z,Zhu L,Wu X
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry (Paraffin)
Mon Mar 15 00:00:00 EDT 2021
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer.
International journal of molecular sciences
Vito A,Rathmann S,Mercanti N,El-Sayes N,Mossman K,Valliant J
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Mon May 03 00:00:00 EDT 2021
Development of a Multiplex Immunohistochemistry Workflow to Investigate the Immune Microenvironment in Mouse Models of Inflammatory Bowel Disease and Colon Cancer.
International journal of molecular sciences
Pang L,Ernst M,Huynh J
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Tue Oct 12 00:00:00 EDT 2021
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells.
iScience
Qadir AS,Guégan JP,Ginestier C,Chaibi A,Bessede A,Charafe-Jauffret E,Macario M,Lavoué V,Rouge TM,Law C,Vilker J,Wang H,Stroup E,Schipma MJ,Bridgeman B,Murmann AE,Ji Z,Legembre P,Peter ME
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Fri Nov 19 00:00:00 EST 2021
Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
International journal of cancer
Raninga PV,Lee AC,Sinha D,Shih YY,Mittal D,Makhale A,Bain AL,Nanayakarra D,Tonissen KF,Kalimutho M,Khanna KK
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Wed Jan 01 00:00:00 EST 2020
Dual Role of Hepatic Macrophages in the Establishment of the Echinococcus multilocularis Metacestode in Mice.
Frontiers in immunology
Wang H,Zhang CS,Fang BB,Hou J,Li WD,Li ZD,Li L,Bi XJ,Li L,Abulizi A,Shao YM,Lin RY,Wen H
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Wed Jun 16 00:00:00 EDT 2021
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice.
Nature communications
Hoefflin R,Harlander S,Schäfer S,Metzger P,Kuo F,Schönenberger D,Adlesic M,Peighambari A,Seidel P,Chen CY,Consenza-Contreras M,Jud A,Lahrmann B,Grabe N,Heide D,Uhl FM,Chan TA,Duyster J,Zeiser R,Schell C,Heikenwalder M,Schilling O,Hakimi AA,Boerries M,Frew IJ
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Mon Aug 17 00:00:00 EDT 2020
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.
Journal for immunotherapy of cancer
Saha D,Rabkin SD,Martuza RL
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Fri May 01 00:00:00 EDT 2020
Shift work influences the outcomes of Chlamydia infection and pathogenesis.
Scientific reports
Lundy SR,Richardson S,Ramsey A,Ellerson D,Fengxia Y,Onyeabor S,Kirlin W,Thompson W,Black CM,DeBruyne JP,Davidson AJ,Immergluck LC,Blas-Machado U,Eko FO,Igietseme JU,He Q,Omosun YO
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Mon Sep 21 00:00:00 EDT 2020
Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer.
Oncoimmunology
Alvero AB,Hanlon D,Pitruzzello M,Filler R,Robinson E,Sobolev O,Tedja R,Ventura A,Bosenberg M,Han P,Edelson RL,Mor G
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Wed May 13 00:00:00 EDT 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice.
Oncoimmunology
Richardson LG,Nieman LT,Stemmer-Rachamimov AO,Zheng XS,Stafford K,Nagashima H,Miller JJ,Kiyokawa J,Ting DT,Wakimoto H,Cahill DP,Choi BD,Curry WT
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunocytochemistry
Thu Aug 20 00:00:00 EDT 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice.
Oncoimmunology
Richardson LG,Nieman LT,Stemmer-Rachamimov AO,Zheng XS,Stafford K,Nagashima H,Miller JJ,Kiyokawa J,Ting DT,Wakimoto H,Cahill DP,Choi BD,Curry WT
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunocytochemistry
Thu Aug 20 00:00:00 EDT 2020
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Journal for immunotherapy of cancer
Bergamaschi C,Pandit H,Nagy BA,Stellas D,Jensen SM,Bear J,Cam M,Valentin A,Fox BA,Felber BK,Pavlakis GN
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Fri May 01 00:00:00 EDT 2020
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity.
Nature communications
von Roemeling CA,Wang Y,Qie Y,Yuan H,Zhao H,Liu X,Yang Z,Yang M,Deng W,Bruno KA,Chan CK,Lee AS,Rosenfeld SS,Yun K,Johnson AJ,Mitchell DA,Jiang W,Kim BYS
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Fri Mar 20 00:00:00 EDT 2020
Enriched environment regulates thymocyte development and alleviates experimental autoimmune encephalomyelitis in mice.
Brain, behavior, and immunity
Xiao R,Bergin SM,Huang W,Mansour AG,Liu X,Judd RT,Widstrom KJ,Queen NJ,Wilkins RK,Siu JJ,Ali S,Caligiuri MA,Cao L
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Tue Jan 01 00:00:00 EST 2019
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
Journal for immunotherapy of cancer
Thomas S,Kuncheria L,Roulstone V,Kyula JN,Mansfield D,Bommareddy PK,Smith H,Kaufman HL,Harrington KJ,Coffin RS
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunocytochemistry
Sat Aug 10 00:00:00 EDT 2019
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
Journal for immunotherapy of cancer
Thomas S,Kuncheria L,Roulstone V,Kyula JN,Mansfield D,Bommareddy PK,Smith H,Kaufman HL,Harrington KJ,Coffin RS
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunocytochemistry
Sat Aug 10 00:00:00 EDT 2019
A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy.
Advanced materials (Deerfield Beach, Fla.)
Mi Y,Smith CC,Yang F,Qi Y,Roche KC,Serody JS,Vincent BG,Wang AZ
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Flow Cytometry
Fri Jun 01 00:00:00 EDT 2018
Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
Clinical cancer research : an official journal of the American Association for Cancer Research
Saha D,Wakimoto H,Peters CW,Antoszczyk SJ,Rabkin SD,Martuza RL
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Sun Jul 15 00:00:00 EDT 2018
Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II.
Oncoimmunology
Li HY,McSharry M,Walker D,Johnson A,Kwak J,Bullock B,Neuwelt A,Poczobutt JM,Sippel TR,Keith RL,Weiser-Evans MCM,Clambey E,Nemenoff RA
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunocytochemistry
Tue Jan 12 00:00:00 EST 2021
Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II.
Oncoimmunology
Li HY,McSharry M,Walker D,Johnson A,Kwak J,Bullock B,Neuwelt A,Poczobutt JM,Sippel TR,Keith RL,Weiser-Evans MCM,Clambey E,Nemenoff RA
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunocytochemistry
Tue Jan 12 00:00:00 EST 2021
C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Cell death & disease
Messenger ZJ,Hall JR,Jima DD,House JS,Tam HW,Tokarz DA,Smart RC
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry (Paraffin)
Mon Oct 15 00:00:00 EDT 2018
hnRNP I regulates neonatal immune adaptation and prevents colitis and colorectal cancer.
PLoS genetics
Jin Z,Liang F,Yang J,Mei W
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Wed Mar 01 00:00:00 EST 2017
Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy.
Oncoimmunology
Yan X,Wang L,Zhang R,Pu X,Wu S,Yu L,Meraz IM,Zhang X,Wang JF,Gibbons DL,Mehran RJ,Swisher SG,Roth JA,Fang B
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Thu Feb 02 00:00:00 EST 2023
Immunotherapeutic target expression on breast tumors can be amplified by hormone receptor antagonism: a novel strategy for enhancing efficacy of targeted immunotherapy.
Oncotarget
Jaini R,Loya MG,Eng C
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Tue May 16 00:00:00 EDT 2017
MAVS-dependent host species range and pathogenicity of human hepatitis A virus.
Science (New York, N.Y.)
Hirai-Yuki A,Hensley L,McGivern DR,González-López O,Das A,Feng H,Sun L,Wilson JE,Hu F,Feng Z,Lovell W,Misumi I,Ting JP,Montgomery S,Cullen J,Whitmire JK,Lemon SM
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Fri Sep 30 00:00:00 EDT 2016
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma.
Cancer immunology, immunotherapy : CII
Kroon P,Gadiot J,Peeters M,Gasparini A,Deken MA,Yagita H,Verheij M,Borst J,Blank CU,Verbrugge I
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Flow Cytometry
Wed Jun 01 00:00:00 EDT 2016
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma.
Cancer immunology, immunotherapy : CII
Kroon P,Gadiot J,Peeters M,Gasparini A,Deken MA,Yagita H,Verheij M,Borst J,Blank CU,Verbrugge I
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Flow Cytometry
Wed Jun 01 00:00:00 EDT 2016
Erythronium japonicum attenuates histopathological lung abnormalities in a mouse model of ovalbumin-induced asthma.
International journal of molecular medicine
Seo JH,Bang MA,Kim G,Cho SS,Park DH
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Sun May 01 00:00:00 EDT 2016
Alpha8 Integrin (Itga8) Signalling Attenuates Chronic Renal Interstitial Fibrosis by Reducing Fibroblast Activation, Not by Interfering with Regulation of Cell Turnover.
PloS one
Marek I,Lichtneger T,Cordasic N,Hilgers KF,Volkert G,Fahlbusch F,Rascher W,Hartner A,Menendez-Castro C
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Thu Jul 28 00:00:00 EDT 2016
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.
Human gene therapy
Wang D,Mou H,Li S,Li Y,Hough S,Tran K,Li J,Yin H,Anderson DG,Sontheimer EJ,Weng Z,Gao G,Xue W
Published figure using CD4 monoclonal antibody (Product # 50-9766-82) in Immunohistochemistry
Wed Jul 01 00:00:00 EDT 2015